Vancomycin Relieves Mycophenolate Mofetil–induced Gastrointestinal Toxicity by Eliminating Gut Bacterial Β-Glucuronidase Activity

Science advances- United States

doi 10.1126/sciadv.aax2358

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

August 1, 2019

Authors

Michael R. Taylor

Kyle L. Flannigan

Simon A. Hirota

Steven C. Greenway

Publisher

American Association for the Advancement of Science (AAAS)

Related search

Targeted Inhibition of Gut Bacterial Β-Glucuronidase Activity Enhances Anticancer Drug Efficacy

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Is Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Drugs in R and D

English

Down-Regulation of Multiple Low Dose Streptozotocin-Induced Diabetes by Mycophenolate Mofetil

Clinical and Experimental Immunology

English

Mycophenolate Mofetil for Drug-Induced Vanishing Bile Duct Syndrome

World Journal of Gastroenterology

Gastroenterology

Danish

Mycophenolate Mofetil Induced Remission in Steroid-Refractory Autoimmune Hemolytic Anemia

Meandros Medical and Dental Journal

English

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology

English

Transient Improvement of Hypertension-Induced Chronic Renal Failure With Mycophenolate Mofetil Treatment

Intensive Care Medicine

English

Β-Glucuronidase (GUSB)

Science-Business eXchange

Occitan

Β-Glucuronidase (GUS)

Science-Business eXchange

Occitan